Search Results - "Biard, L."

Takayasu Arteritis and Pregnancy by Comarmond, C., Mirault, T., Biard, L., Nizard, J., Lambert, M., Wechsler, B., Hachulla, E., Chiche, L., Koskas, F., Gaudric, J., Cluzel, P., Messas, E., Resche‐Rigon, M., Piette, J. C., Cacoub, P., Saadoun, D.

“…Objective To assess the relationship between Takayasu arteritis (TAK) and pregnancy outcome. Methods This study included 240 pregnancies in 96 patients…”
Get full text

Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer by Groheux, David, Biard, L., Lehmann-Che, J., Teixeira, L., Bouhidel, F. A., Poirot, B., Bertheau, P., Merlet, P., Espié, M., Resche-Rigon, M., Sotiriou, C., de Cremoux, P.

“…Purpose Survival is increased when pathological complete response (pCR) is reached after neoadjuvant chemotherapy (NAC), especially in triple-negative breast…”
Get full text

Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients by Desbois, A.C., Biard, L., Addimanda, O., Lambert, M., Hachulla, E., Launay, D., Ackermann, F., Pérard, L., Hot, A., Maurier, F., Mausservey, C., Bernard, F., Noel, N., Alric, L., Mirault, T., Cohen, F., Boussouar, S., Resche-Rigon, M., Cacoub, P., Saadoun, D.

“…To describe the outcome and tolerance in patients treated with anti-TNFα in severe and refractory major vessel disease in Behçet's disease (BD). A multicenter…”
Get full text

Investigating covariate-by-centre interaction in survival data by Biard, L, Labopin, M, Chevret, S, Resche-Rigon, M

“…In survival analysis, assessing the existence of potential centre effects on the baseline hazard or on the effect of fixed covariates on the baseline hazard,…”
Get full text

Permutation tests for centre effect on survival endpoints with application in an acute myeloid leukaemia multicentre study by Biard, L., Porcher, R., Resche-Rigon, M.

“…When analysing multicentre data, it may be of interest to test whether the distribution of the endpoint varies among centres. In a mixed‐effect model, testing…”
Get full text

Incidence, risk factors, and outcome of multidrug-resistant Acinetobacter baumannii acquisition during an outbreak in a burns unit by Munier, A.-L., Biard, L., Rousseau, C., Legrand, M., Lafaurie, M., Lomont, A., Donay, J.-L., de Beaugrenier, E., Flicoteaux, R., Mebazaa, A., Mimoun, M., Molina, J.-M.

“…Multidrug-resistant Acinetobacter baumannii (MR-AB) can cause outbreaks in a burns unit. To study the incidence, risk factors and outcome of MR-AB colonization…”
Get full text

Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt by Bonnard, P., Elsharkawy, A., Zalata, K., Delarocque-Astagneau, E., Biard, L., Le Fouler, L., Hassan, A. B., Abdel-Hamid, M., El-Daly, M., Gamal, M. E., El Kassas, M., Bedossa, P., Carrat, F., Fontanet, A., Esmat, G.

“…Summary In Egypt, as elsewhere, liver biopsy (LB) remains the gold standard to assess liver fibrosis in chronic hepatitis C (CHC) and is required to decide…”
Get full text

Long-term outcome of infliximab in severe chronic and refractory systemic sarcoidosis: a report of 16 cases by Chapelon-Abric, Catherine, Saadoun, David, Biard, Lucie, Sene, Damien, Resche-Rigon, Matthieu, Hervier, Baptiste, Costedoat-Chalumeau, Nathalie, Drier, Aurelie, Leger, Jean Marc, Cacoub, Patrice

“…Infliximab (IFX) appears to be effective in refractory sarcoidosis. However, data are lacking regarding its efficacy in severe sarcoidosis (i.e. with cardiac…”
Get full text

Severe atypical pneumonia in critically ill patients: a retrospective multicenter study by Valade, S., Biard, L., Lemiale, V., Argaud, L., Pène, F., Papazian, L., Bruneel, F., Seguin, A., Kouatchet, A., Oziel, J., Rouleau, S., Bele, N., Razazi, K., Lesieur, O., Boissier, F., Megarbane, B., Bigé, N., Brulé, N., Moreau, A. S., Lautrette, A., Peyrony, O., Perez, P., Mayaux, J., Azoulay, E.

“…Background Chlamydophila pneumoniae (CP) and Mycoplasma pneumoniae (MP) patients could require intensive care unit (ICU) admission for acute respiratory…”
Get full text

Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status by Servais, S., Dumontier, N., Biard, L., Schnepf, N., Resche-Rigon, M., Peffault de Latour, R., Scieux, C., Robin, M., Meunier, M., Xhaard, A., Sicre de Fontbrune, F., Le Goff, J., Socié, G., Simon, F., Mazeron, M.-C.

“…Pre-emptive antiviral treatment efficiently prevents occurrence of cytomegalovirus (CMV) disease in allogeneic stem cell transplant recipients. However,…”
Get full text

Existence conditions for Coons patches interpolating geodesic boundary curves by Farouki, R.T., Szafran, N., Biard, L.

“…Given two pairs of regular space curves r 1 ( u ) , r 3 ( u ) and r 2 ( v ) , r 4 ( v ) that define a curvilinear rectangle, we consider the problem of…”
Get full text

Construction of Bézier surface patches with Bézier curves as geodesic boundaries by Farouki, R.T., Szafran, N., Biard, L.

“…Given four polynomial or rational Bézier curves defining a curvilinear rectangle, we consider the problem of constructing polynomial or rational tensor-product…”
Get full text

Surface reconstruction via geodesic interpolation by Sprynski, N., Szafran, N., Lacolle, B., Biard, L.

“…This paper is concerned with reconstruction of numerical or real surfaces based on the knowledge of some geodesic curves on the surface. So, considering two…”
Get full text

Construction and smoothing of triangular Coons patches with geodesic boundary curves by Farouki, R.T., Szafran, N., Biard, L.

“…Given three regular space curves r 1 ( t ) , r 2 ( t ) , r 3 ( t ) for t ∈ [ 0 , 1 ] that define a curvilinear triangle, we consider the problem of…”
Get full text

ALLOGENEIC UMBILICAL-CORD DERIVED MESENCHYMAL STROMAL CELLS MSC(UC) AS TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): SAFETY AND EARLY CLINICAL/BIOLOGICAL RESULTS FROM A PHASE I-II PROOF-OF-CONCEPT CLINICAL STUDY by Farge, D., Biard, L., Weil, B., Loisel, S., LANSIAUX, P., Munia, I., Girault, V., Charles, C., Korganow, A., Beuvon, C., Pugnet, G., Cacciatore, C., Abisror, N., Taupin, J., Cras, A., Lowdell, M., Tarte, K.

“…Preclinical studies show Mesenchymal Stromal Cells (MSC) unique immunomodulatory, proangiogenic, and antifibrotic effects. Few clinical data report MSC use to…”
Get full text

Minkowski isoperimetric-hodograph curves by Ait-Haddou, R., Biard, L., Slawinski, M.A.

“…General offset curves are treated in the context of Minkowski geometry, the geometry of the two-dimensional plane, stemming from the consideration of a…”
Get full text

Minimizing blossoms under symmetric linear constraints by Ait-Haddou, R., Biard, L., Slawinski, M.A.

“…In this paper, we show that there exists a close dependence between the control polygon of a polynomial and the minimum of its blossom under symmetric linear…”
Get full text

Pneumonie grave à SARS-Cov2 chez les patients vaccinés : une étude multicentrique by Mirouse, A., Friol, A., Moreau, A.S., Jung, B., Jullien, E., Bureau, C., Djibre, M., De Prost, N., Zafrani, L., Argaud, L., Reuter, D., Calvet, L., De Montmollin, E., Benghanem, S., Pichereau, C., Pham, T., Cacoub, P., Biard, L., Saadoun, D.

Get full text

Behcet's disease in Budd-Chiari syndrome by Desbois, Anne Claire, Rautou, Pierre Emmanuel, Biard, Lucie, Belmatoug, Nadia, Wechsler, Bertrand, Resche-Rigon, Mathieu, Zarrouk, Virginie, Fantin, Bruno, de Chambrun, M Pineton, Cacoub, Patrice, Valla, Dominique, Saadoun, David, Plessier, Aurélie

“…Behcet's disease (BD) is a well-known cause of Budd-Chiari syndrome (BCS). Data are lacking on the presentation and outcome of BCS related to BD. We…”
Get full text

Impact des traitements immunodépresseurs sur les lésions vasculaires à l’angioscanner chez les patients avec une maladie de Takayasu by Bletry, D., Meyblum, L., Kristelle, D., Vautier, M., Cacoub, P., Chiche, L., Roux, C., Gaudric, J., Biard, L., Saadoun, D.

Get full text